92 related articles for article (PubMed ID: 24481573)
1. Glioblastoma-associated stromal cells (GASCs) from histologically normal surgical margins have a myofibroblast phenotype and angiogenic properties.
Clavreul A; Guette C; Faguer R; Tétaud C; Boissard A; Lemaire L; Rousseau A; Avril T; Henry C; Coqueret O; Menei P
J Pathol; 2014 May; 233(1):74-88. PubMed ID: 24481573
[TBL] [Abstract][Full Text] [Related]
2. Implantable SDF-1α-loaded silk fibroin hyaluronic acid aerogel sponges as an instructive component of the glioblastoma ecosystem: Between chemoattraction and tumor shaping into resection cavities.
Molina-Peña R; Ferreira NH; Roy C; Roncali L; Najberg M; Avril S; Zarur M; Bourgeois W; Ferreirós A; Lucchi C; Cavallieri F; Hindré F; Tosi G; Biagini G; Valzania F; Berger F; Abal M; Rousseau A; Boury F; Alvarez-Lorenzo C; Garcion E
Acta Biomater; 2024 Jan; 173():261-282. PubMed ID: 37866725
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin.
Piccirillo SG; Dietz S; Madhu B; Griffiths J; Price SJ; Collins VP; Watts C
Br J Cancer; 2012 Jul; 107(3):462-8. PubMed ID: 22722315
[TBL] [Abstract][Full Text] [Related]
4. Cell-to-cell communication mediates glioblastoma progression in
Portela M; Mitchell T; Casas-Tintó S
Biol Open; 2020 Sep; 9(9):. PubMed ID: 32878880
[TBL] [Abstract][Full Text] [Related]
5. Evolutionary dynamics of residual disease in human glioblastoma.
Spiteri I; Caravagna G; Cresswell GD; Vatsiou A; Nichol D; Acar A; Ermini L; Chkhaidze K; Werner B; Mair R; Brognaro E; Verhaak RGW; Sanguinetti G; Piccirillo SGM; Watts C; Sottoriva A
Ann Oncol; 2019 Mar; 30(3):456-463. PubMed ID: 30452544
[TBL] [Abstract][Full Text] [Related]
6. The Role of Microglia in Glioblastoma.
Geribaldi-Doldán N; Fernández-Ponce C; Quiroz RN; Sánchez-Gomar I; Escorcia LG; Velásquez EP; Quiroz EN
Front Oncol; 2020; 10():603495. PubMed ID: 33585220
[TBL] [Abstract][Full Text] [Related]
7. A New Systemic Disease Mouse Model for Glioblastoma Capable of Single-Tumour-Cell Detection.
Ware TMB; Luwor RB; Zhu HJ
Cells; 2024 Jan; 13(2):. PubMed ID: 38275817
[TBL] [Abstract][Full Text] [Related]
8. New perspectives in glioblastoma antiangiogenic therapy.
Popescu AM; Purcaru SO; Alexandru O; Dricu A
Contemp Oncol (Pozn); 2016; 20(2):109-18. PubMed ID: 27358588
[TBL] [Abstract][Full Text] [Related]
9. In preprints: recapitulation of development and wound healing shapes the spatial organization of glioblastoma.
Kameneva P; Taschner-Mandl S
Development; 2024 Jan; 151(1):. PubMed ID: 38180240
[No Abstract] [Full Text] [Related]
10. Effect of cancer-associated fibroblasts on the migration of glioma cells in vitro.
Trylcova J; Busek P; Smetana K; Balaziova E; Dvorankova B; Mifkova A; Sedo A
Tumour Biol; 2015 Aug; 36(8):5873-9. PubMed ID: 25712375
[TBL] [Abstract][Full Text] [Related]
11. Identification of two glioblastoma-associated stromal cell subtypes with different carcinogenic properties in histologically normal surgical margins.
Clavreul A; Etcheverry A; Tétaud C; Rousseau A; Avril T; Henry C; Mosser J; Menei P
J Neurooncol; 2015 Mar; 122(1):1-10. PubMed ID: 25503303
[TBL] [Abstract][Full Text] [Related]
12. Glioblastoma-Associated Mesenchymal Stem/Stromal Cells and Cancer-Associated Fibroblasts: Partners in Crime?
Lootens T; Roman BI; Stevens CV; De Wever O; Raedt R
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396962
[TBL] [Abstract][Full Text] [Related]
13. Pan-cancer ion transport signature reveals functional regulators of glioblastoma aggression.
Bahcheli AT; Min HK; Bayati M; Zhao H; Fortuna A; Dong W; Dzneladze I; Chan J; Chen X; Guevara-Hoyer K; Dirks PB; Huang X; Reimand J
EMBO J; 2024 Jan; 43(2):196-224. PubMed ID: 38177502
[TBL] [Abstract][Full Text] [Related]
14. Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma.
Galbo PM; Madsen AT; Liu Y; Peng M; Wei Y; Ciesielski MJ; Fenstermaker RA; Graff S; Montagna C; Segall JE; Sidoli S; Zang X; Zheng D
Clin Cancer Res; 2024 Feb; 30(4):865-876. PubMed ID: 38060213
[TBL] [Abstract][Full Text] [Related]
15. Current Knowledge about the Peritumoral Microenvironment in Glioblastoma.
Trevisi G; Mangiola A
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001721
[TBL] [Abstract][Full Text] [Related]
16. Engineering the glioblastoma microenvironment with bioactive nanoparticles for effective immunotherapy.
Blanchard R; Adjei I
RSC Adv; 2023 Oct; 13(45):31411-31425. PubMed ID: 37901257
[TBL] [Abstract][Full Text] [Related]
17. Role of Oxidative Stress in Metabolic Reprogramming of Brain Cancer.
Agrawal K; Asthana S; Kumar D
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894287
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria Transfer from Mesenchymal Stem Cells Confers Chemoresistance to Glioblastoma Stem Cells through Metabolic Rewiring.
Nakhle J; Khattar K; Özkan T; Boughlita A; Abba Moussa D; Darlix A; Lorcy F; Rigau V; Bauchet L; Gerbal-Chaloin S; Daujat-Chavanieu M; Bellvert F; Turchi L; Virolle T; Hugnot JP; Buisine N; Galloni M; Dardalhon V; Rodriguez AM; Vignais ML
Cancer Res Commun; 2023 Jun; 3(6):1041-1056. PubMed ID: 37377608
[TBL] [Abstract][Full Text] [Related]
19. Cancer Stem Cells in Tumours of the Central Nervous System in Children: A Comprehensive Review.
Han YP; Lin HW; Li H
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370764
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
